Profile
Lawrence John Wood formerly worked at Exogenesis Corp., as President & Chief Executive Officer, enGene, Inc., as Chairman from 2004 to 2010, QLT, Inc., as Director in 2001, Clinuvel Pharmaceuticals Ltd., as Independent Non-Executive Director from 2008 to 2014, West Vancouver Shoreline Preservation Society, as Treasurer & Director, Bio Response, Inc., as Senior Vice President from 1988 to 1990, Bayer Corp., as Vice President & General Manager-Europe from 1980 to 1988, and CSL Ltd., as Executive Vice President.
Former positions of Lawrence John Wood
| Companies | Position | End |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Director/Board Member | 2014-07-27 |
| West Vancouver Shoreline Preservation Society | Director/Board Member | 2014-07-27 |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Chairman | 2010-11-30 |
Bio Response, Inc.
 Bio Response, Inc. Miscellaneous Commercial ServicesCommercial Services Bio Response, Inc. provides marketing and distribution services. The private company is based in Brooklyn, NY and has subsidiaries in the United States. | Corporate Officer/Principal | 1989-12-31 |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Corporate Officer/Principal | 1987-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CSL LIMITED | Health Technology |
| CLINUVEL PHARMACEUTICALS LIMITED | Health Technology |
| Private companies | 6 |
|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Bio Response, Inc.
Bio Response, Inc. Miscellaneous Commercial ServicesCommercial Services Bio Response, Inc. provides marketing and distribution services. The private company is based in Brooklyn, NY and has subsidiaries in the United States. | Commercial Services |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Health Technology |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Health Technology |
Exogenesis Corp.
 Exogenesis Corp. Medical SpecialtiesHealth Technology Exogenesis Corp. processes implantable medical devices and other medical products. It is engaged in development activities with a number of partners and is interested in exploring new applications for its technology in biomedical and non-medical applications with partners interested in improving the properties and performance of materials. The company was founded by Richard C. Svrluga in 2005 and is headquartered in Billeric, MA. | Health Technology |
| West Vancouver Shoreline Preservation Society |
- Stock Market
- Insiders
- Lawrence John Wood